Viventia Biotech Inc.

Viventia Biotech Inc. (formerly Novopharm Biotech Inc.) is a leading Canadian biopharmaceutical company engaged in the research, development and commercialization of both innovative and generic biopharmaceutical products.
The company features expertise in novel cancer therapies and diagnostics, innovative therapeutics based upon the human immune response to cancer. Through its Hybridomics™ discovery platform and ImmunoMine™ screening technology, the Company is focused on developing Totally Human monoclonal antibodies either as targeted therapeutics, Armed Antibodies™, or as direct treatments to fight multiple forms of cancer.

Activity:

- Manufacturing
- Research & Development

Product / Technology type(s) covered:

- Bio
- Diagnostics
- Drug delivery
- Generics
- Pharmaceuticals / Therapeutics
- Technology

Therapeutic targets:

- Cancer

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:
	2001

Year founded: